Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome

New England Journal of Medicine

Volumn 370, Issue 2, 2014, Pages 129-138

  Klootwijk, Enriko D ^a   Reichold, Markus ^d   Helip Wooley, Amanda ^f   Tolaymat, Asad ^h   Broeker, Carsten ^d   Robinette, Steven L ^c,f   Reinders, Joerg ^d   Peindl, Dominika ^d   Renner, Kathrin ^d   Eberhart, Karin ^d   Assmann, Nadine ^d   Oefner, Peter J ^d   Dettmer, Katja ^d   Sterner, Christina ^d   Schroeder, Josef ^d   Zorger, Niels ^e   Witzgall, Ralph ^d   Reinhold, Stephan W ^d   Stanescu, Horia C ^a,f   Bockenhauer, Detlef ^a,b   Jaureguiberry, Graciana ^a   Courtneidge, Holly ^a   Hall, Andrew M ^a   Wijeyesekera, Anisha D ^c   Holmes, Elaine ^c   Nicholson, Jeremy K ^c   O'Brien, Kevin ^f   Bernardini, Isa ^f   Krasnewich, Donna M ^f   Arcos Burgos, Mauricio ⁱ   Izumi, Yuichiro ^g   Nonoguchi, Hiroshi ^j   Jia, Yuzhi ^k   Reddy, Janardan K ^k   Ilyas, Mohammad ^h   Unwin, Robert J ^a   Gahl, William A ^f   Warth, Richard ^d   Kleta, Robert ^a,b,f   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e Hospital Barmherzige Brueder   (Germany)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^j KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

^k NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892566155     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1307581     Document Type: Article

References (31)

1. Kleta R, Gahl WA. Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 2002;13:2189-91.
2. Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 2011;57: 773-80.
3. Ciarimboli G, Holle SK, Vollenbröcker B, et al. New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Mol Pharm 2011;8:270-9.
4. Kleta R. Fanconi or not Fanconi? Lowe syndrome revisited. Clin J Am Soc Nephrol 2008;3:1244-5.
5. Szeto HH, Liu S, Soong Y, et al. Mito-chondria- targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 2011;22:1041-52.
6. Hall AM. Pores for thought: new strategies to re-energize stressed mitochondria in acute kidney injury. J Am Soc Nephrol 2011;22:986-9.
7. Vilasi A, Cutillas PR, Maher AD, et al. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 2007;293:F456-F467.
8. Landouré G, Zdebik AA, Martinez TL, et al. Mutations in TRPV4 cause Charcot- Marie-Tooth disease type 2C. Nat Genet 2010;42:170-4.
9. Izumi Y, Nakayama Y, Mori T, et al. Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway. Am J Physiol Renal Physiol 2007;292:F1418-F1426.
10. Kleta R, Mohrmann M, Schlatter E. Effects of cell differentiation on ion conductances and membrane voltage in LLC-PK1 cells. Pflugers Arch 1995;429:370-7.
11. Dettmer K, Nürnberger N, Kaspar H, Gruber MA, Almstetter MF, Oefner PJ. Metabolite extraction from adherently growing mammalian cells for metabolomics studies: optimization of harvesting and extraction protocols. Anal Bioanal Chem 2011;399:1127-39.
12. Stadlmann S, Renner K, Pollheimer J, et al. Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. Cell Biochem Biophys 2006;44:179-86.
13. Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cell cultures and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 2012;810:25-58.
14. Qi C, Zhu Y, Pan J, et al. Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver: further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism. J Biol Chem 1999;274:15775-80.
15. Kaspar H, Dettmer K, Gronwald W, Oefner PJ. Automated GC-MS analysis of free amino acids in biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 2008;870:222-32.
16. Tolaymat A, Sakarcan A, Neiberger R. Idiopathic Fanconi syndrome in a family. Part I: clinical aspects. J Am Soc Nephrol 1992;2:1310-7.
17. Claros MG, Vincens P. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur J Biochem 1996;241:779-86.
18. Hull RN, Cherry WR, Weaver GW. The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro 1976;12:670-7.
19. Kleta R, Bockenhauer D. Bartter syndromes and other salt-losing tubulopathies. Nephron Physiol 2006;104:p73-p80.
20. Kleta R, Bernardini I, Ueda M, et al. Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 2004; 145:555-60.
21. Bockenhauer D, Bokenkamp A, van't Hoff W, et al. Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol 2008; 3:1430-6.
22. Magen D, Sprecher E, Zelikovic I, Skorecki K. A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria. Kidney Int 2005;67:34-41.
23. Magen D, Berger L, Coady MJ, et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med 2010;362:1102-9.
24. Foreman JW, Roth KS. Human renal Fanconi syndrome - then and now. Nephron 1989;51:301-6.
25. Balaban RS, Mandel LJ. Metabolic substrate utilization by rabbit proximal tubule: an NADH fluorescence study. Am J Physiol 1988;254:F407-F416.
26. Niaudet P, Rötig A. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 1996;10:368-73.
27. Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferatoractivated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001;21:193-230.
28. Wanders RJ, Vreken P, Ferdinandusse S, et al. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 2001;29:250-67.
29. Houten SM, Denis S, Argmann CA, et al. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. J Lipid Res 2012;53:1296-303.
30. Danpure CJ. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Biochim Biophys Acta 2006; 1763:1776-84.
31. Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med 2012;366:1132-41.